The National Health Council (NHC) considers first and foremost its mission and serving its constituents in all decisions, including whether to enter into a relationship with a for-profit entity. In many cases, activities that fulfill the NHC's mission cannot be accomplished as well alone as they can be through collaboration and alliances among like-minded organizations. It is for this reason that the National Health Council seeks to forge appropriate and productive collaborative relationships with corporations and others. These relationships are entered into thoughtfully, with careful consideration given to possible unintended effects, especially regarding the organization's relationship with the public.

The National Health Council will, unless otherwise prohibited by law, disclose the financial support it receives from those corporations identified on Schedule B of the IRS Form 990.

The disclosure information will be posted on the NHC's website in an easily accessible location within six months of the close of the fiscal year.

Corporations will be grouped into monetary ranges for purposes of disclosure. The disclosure information will also include the total amount of support received from all corporations.

Click here to view the full National Health Council Policy on Corporate Relationships.

NOTE: Disclosure information for the year 2016 will be posted in 2017.


National Health Council Sponsors

These companies and organizations have provided educational grants and sponsorships for the National Health Council's many programs and educational initiatives, such as the annual Health Leadership Conference. We gratefully acknowledge their support.

2015 Donation Range 

Up to $50,000:

Advanced Medical Technology Association
Alpha-1 Foundation
American Heart Association
Astellas Pharma US
Barth Syndrome Foundation
Biotechnology Industry Organization
Boehringer Ingelheim Pharmaceuticals
Bristol-Myers Squibb
COPD Foundation
Hydrocephalus Association
Johnson & Johnson
March of Dimes Foundation
National Alopecia Areata Foundation
National Osteoporosis Foundation
National Pharmaceutical Council
National Psoriasis Foundation
RESOLVE: The National Infertility Association
Sjogren's Syndrome Foundation
WomenHeart: The National Coalition for Women with Heart Disease

$50,001 to $100,000:

AstraZeneca Pharmaceuticals 
Novo Nordisk

$100,001 to $250,000:

Merck & Co.

$250,001 to $500,000:

Eli Lilly and Company
Pfizer Inc
Pharmaceutical Research and Manufacturers of America